key: cord-0848424-0cenfm97 authors: Wang, Wenhao; Peng, Xiaoxue; Jin, Yunyun; Pan, Ji‐An; Guo, Deyin title: Reverse genetics systems for SARS‐CoV‐2 date: 2022-04-05 journal: J Med Virol DOI: 10.1002/jmv.27738 sha: b8aef3b51ed7f773f1fed84650e7fca37efccd0f doc_id: 848424 cord_uid: 0cenfm97 The ongoing pandemic of coronavirus disease 2019 (COVID‐19) has caused severe public health crises and heavy economic losses. Limited knowledge about this deadly virus impairs our capacity to set up a toolkit against it. Thus, more studies on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) biology are urgently needed. Reverse genetics systems, including viral infectious clones and replicons, are powerful platforms for viral research projects, spanning many aspects such as the rescues of wild‐type or mutant viral particles, the investigation of viral replication mechanism, the characterization of viral protein functions, and the studies on viral pathogenesis and antiviral drug development. The operations on viral infectious clones are strictly limited in the Biosafety Level 3 (BSL3) facilities, which are insufficient, especially during the pandemic. In contrast, the operation on the noninfectious replicon can be performed in Biosafety Level 2 (BSL2) facilities, which are widely available. After the outbreak of COVID‐19, many reverse genetics systems for SARS‐CoV‐2, including infectious clones and replicons are developed and given plenty of options for researchers to pick up according to the requirement of their research works. In this review, we summarize the available reverse genetics systems for SARS‐CoV‐2, by highlighting the features of these systems, and provide a quick guide for researchers, especially those without ample experience in operating viral reverse genetics systems. After binding to receptors, such as the human angiotensin-converting enzyme 2 (ACE2), the S glycoprotein of SARS-CoV-2 undergoes proteolysis by transmembrane protease serine 2 (TMPRSS2) and other proteases, triggering the conformational changes of S2 subunit and the fusion of viral and cellular membranes. 10 Once entering into the permissive cell, the coronavirus releases its genomic RNA from nucleocapsid structure, ready for translation and following transcription/replication. 11, 12 The 30-kb genomic RNA of SARS-CoV-2 comprises more than nine open-reading frames (ORFs) and is flanked by two untranslated regions (UTRs) at 5′ and 3′ terminus, respectively. Similar to the host messenger RNA (mRNA), the viral genomic RNA possesses a 5′ cap and a 3′ ploy (A) tail structure. The viral genomic RNA uses its ORF1a and ORF1ab to express polyproteins 1a and 1ab (pp1a and pp1ab). The latter's expression requires a −1 ribosomal frameshift process. The polyproteins are processed into 16 nonstructural proteins (nsps) with their own papain-like proteinase activity in nsp3 and 3C-like proteinase activity in nsp5. 2, 13, 14 Although many details are still missing, it is well recognized that the many nsps are assembled into a replication/ transcription complex (RTC) to synthesize the viral negative-or positive-sense genomic and subgenomic RNAs. 16, 17 Through the mechanism of discontinuous transcription/ replication, the viral RTC generated the viral subgenomic RNAs. 3, 18 Nine transcriptional regulatory sequences (TRSs), one in 5′ UTR and eight in the body sequence of 3′ terminal part of the genomic RNA, play essential roles in the discontinuous replication of viral genomic RNA, by forming the junctures between the sequence before the TRS in 5′ UTR (named leader sequence), and the sequence after the TRSs in 3′ terminal art of genomic RNA (named body sequences). 12, 14, 18 Using the subgenomic RNAs, the ORFs in 3′ terminus of genomic RNA encode four well-known structural proteins, S, E, M, and N, and a set of accessory proteins, whose functions still await further investigation. 15 The coronaviruses adopt a delicate and complex replication mechanism, in which a number of viral component proteins are involved. However, this mechanism also makes the virus vulnerable to the inhibitory effect caused by drugs or other factors targeting the component proteins or the association between them. 19 The inhibitory effect of the drugs can be verified with the model of virusinfected cells, which is strictly required to be carried out in BSL3 facilities. The limited availability of BSL3 facility, especially in ongoing pandemics, becomes an obstacle to live virus-associated research. 20 Furthermore, the model of virus-infected cells is not an ideal system for investigating the mechanistic details, which are more conveniently and feasibly investigated using the biosafe replicon, modified from the infectious reverse genetics system. 14 The reverse genetic systems for emerging coronaviruses, including SARS-CoV-2, SARS-CoV, MERS-CoV, and many coronaviruses, have been developed through various strategies, which can be categorized into RNA-and cDNA-recombination based strategies. In this report, we review and discuss various strategies for the construction of reverse genetics systems, especially those for SARS-CoV-2 (Table 1) , and share the experience in the operation of the reverse genetics systems. The first reverse genetics system for coronavirus was successfully constructed with a targeted RNA recombination strategy. [21] [22] [23] Homologous RNA recombination is common in regions with high sequence similarity during viral RNA replication. 24 Lai et al. first reported that RNA recombination mediates the fusion of RNA of different mouse hepatitis virus (MHV) strains during genome replication. 25 Moreover, targeted RNA recombination is applied in introducing site-specific mutations into the genome of coronavirus by using defective interfering (DI) RNA as the donor. 26, 27 A host range-based positive selection strategy was developed to expand the application of targeted RNA recombination. 28 In this system, a mutant MHV was created, in which the ectodomain of the S protein was replaced with its counterpart of other coronaviruses, leading to an expanded range of hosts ( Figure 1 ). 28 Besides MHV, the targeted RNA recombination strategy has been employed to construct reverse genetics systems of other coronaviruses, including feline infectious peritonitis virus (FIPV) and porcine epidemic diarrhea virus (PEDV). 29, 30 Targeted RNA recombination is very useful for studying the approximately 9 kb sequence at 3′ terminus of the coronaviral genome. However, this strategy becomes incompetent to manipulate the replicase gene sequence upstream of the S gene. The first reason is the large size of the replicase gene (more than 20 kb). The second more important reason is the strategy's dependence on viral passage, which is mediated by the viral replicase gene. The viral passage could be impaired when the viral replicase gene is manipulated by targeted RNA recombination. 31 Thus, targeted RNA recombination is ineffective in dealing with the questions about the viral replication/ transcription mechanism, which is usually more feasibly investigated with the viral cDNA recombination-based strategies. This BAC-based strategy has been successfully utilized to construct the full-length cDNA clones of various coronaviruses, including TGEV, 33 HCoV-OC43, 40 FIPV, 41 SARS-CoV, 42 MERS-CoV, 43 39, 47, 48 The latter contains pGEM vector-derived LacZα reporter gene for screening the clones with inserts. 39 The F-factor in BAC plasmid ensures that each daughter cell obtains one copy of BAC plasmid during the bacteria division, 49 The full-length viral cDNA is usually separated into a few fragments for assembly, which is usually lower than 6 kb, mostly due to the cloning efficiency. 51 All the adjacent fragments are ligated at the unique restriction sites, the selection of which is critical for both construction and future reconstruction of fulllength viral clones. 14 When the unique restriction sites are not enough to separate the viral cDNA into the desired size of fragments, new restriction sites are generated by introducing the silent mutations, which can also be used as the genetic marker for viral full-length cDNA clones. 14 It is worthy to note that the ethanol precipitation method can achieve a decent recovery efficiency and fewer damages on digested fragments and BAC plasmids compared with many DNA recovery approaches. BAC plasmid containing multiple cloning sites, including all the designed restriction sites for fragment assembly, is helpful for the downstream cloning work, though it is not indispensable. In theory, the fragments could be inserted in the BAC plasmid in any order with the unique restriction sites. However, due to the potential toxicity of viral sequence around nsp8-nsp12 for many coronaviruses, the fragments covering this region could be left last to handle. 14, 38 In our laboratory practice, we find that the positive colony percentage notably drops while assembling this region into viral cDNA clones. Besides BAC, while constructing the full-length clone for SARS-CoV, we successfully assembled the full-length viral cDNA into the pBR322-derived vector, which generates 10-20 copies per E. coli cell. However, pBR322 cannot maintain the fidelity of cDNA, for the sequence covering nsp8-nsp12 is prone to bear the unexpected insertions or deletions, which orchestrate the increased yield of plasmids while performing the DNA extraction from the bacteria (unpublished data). Although the viral cDNA is usually maintained stably in the BAC vector, sequencing is still recommended to ensure no undesired mutations, especially at those unstable regions in ORF1, which could happen during the cloning steps or amplification in the bacteria. The instability of ORF1 region could be ameliorated by using introns to separate the instable regions into two or more segments. 38 During In their design, the full-length cDNA of TGEV was separated into five contiguous fragments (Fragment A-F), which is generated by specific primer-guided RT-PCR. Each fragment is flanked with desired BglI restriction sites and then cloned into the individual plasmid for unlimited production of materials. 62 To "detoxify" poisonous TGEV sequences in E. coli, Baric F I G U R E 3 Reverse genetics system based on the in vitro ligation. Seven contiguous complementary DNA (cDNA) fragments covering the entire severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome were flanked by unique type IIS restriction endonucleases sites, which was adopted by No See′m cloning technology. F1 was fused with T7 promoter at its 5′ terminus. The fragments were cloned into a high-copy plasmid for unlimited production. Each fragment was cleaved out of the plasmid with designed type IIS restriction endonucleases, purified from the gel, and ligated to each other to assemble the full-length cDNA of SARS-CoV-2, which was transcribed with T7 polymerase to generate the infectious full-length viral genomic RNA. 54 replicons. For those studies in the conditions with critical biosafety concerns and lack of BSL3 facility, BAC-based strategy has apparent advantages in the assays related to the quantitative comparison between the wild-type and mutant replicons and high-throughput screening work, which are easily performed with a regular transfection on mammalian cells. 3.3 | Reverse genetics system using yeast-based TAR cloning The size limit and instability of viral sequence are the major obstacles to cloning the full-length cDNA of coronaviruses into a replicable vector. The BAC-based strategy has successfully cloned the fulllength cDNA of many coronaviruses, as mentioned above, but the toxicity of some viral sequences to bacteria hinders the cloning work. The suitability of yeast S. cerevisiae to assemble and maintain genomes of coronaviruses was proven by the successful construction of an infectious full-length cDNA clone of MHV-A59 using yeastbased TAR cloning. 35 The genomic RNA of MHV-A59 obtained from MHV-infected mouse 17Cl-1 cells was used as the template to amplify seven overlapping DNA fragments with RT-PCR. 35 The fragments by replacing fragment 11 with three sub-fragments to insert a GFP reporter gene for antiviral drugs screening 35 (Table 1 and Figure 4) . Due to the page limit, we cannot give comprehensive descriptions of all the works constructing the reverse genetics system of SARS-CoV-2. [75] [76] [77] [78] Besides the reverse genetics system constructed with the strategies mentioned above, Luo et al. successfully used the fragmented replicase polyproteins to drive the replication of viral mini replicon, F I G U R E 5 Reverse genetics system based on circular polymerase extension reaction strategy (CPER). Ten contiguous fragments with overlapping ends covered the viral full-length complementary DNA (cDNA) and were generated by polymerase chain reaction (PCR) with specific primers. A linker fragment containing the overlapping sequence with 3′ end of severe acute respiratory syndrome coronavirus consisting of viral 5′ UTR, reporter gene, and viral poly (A) in order. 79 Although the chance for it is low, BSL3 conditions are highly recommended. The authors agreed to participate in the project. All authors read and approved the final manuscript for publication. Ten-thousand Talents Program. The authors declare no conflicts of interest. Pandemics throughout history A pneumonia outbreak associated with a new coronavirus of probable bat origin Emerging coronaviruses: genome structure, replication, and pathogenesis A novel coronavirus from patients with pneumonia in China Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention Characteristics of SARS-CoV-2 and COVID-19 Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). StatPearls Controversy around airborne versus droplet transmission of respiratory viruses: implication for infection prevention Airborne transmission of respiratory viruses SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor The molecular biology of coronaviruses Coronavirus biology and replication: implications for SARS-CoV-2 Oxidative stress transforms 3CLpro into an insoluble and more active form to promote SARS-CoV-2 replication A convenient and biosafe replicon with accessory genes of SARS-CoV-2 and its potential application in antiviral drug discovery Genome-wide analysis of proteinprotein interactions and involvement of viral proteins in SARS-CoV-2 replication Structure of the RNA-dependent RNA polymerase from COVID-19 virus Structural and biochemical characterization of the nsp12-nsp7-nsp8 core polymerase complex from SARS-CoV-2 Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods The COVID-19 pandemics and the relevance of biosafety facilities for metagenomics surveillance, structured disease prevention and control Rescue of SARS-CoV-2 from a single bacterial artificial chromosome Construction of a noninfectious SARS-CoV-2 replicon for antiviral-drug testing and gene function studies Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2 A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research An Infectious cDNA Clone of SARS-CoV-2 SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract SARS-CoV-2 replicon for highthroughput antiviral screening A novel cell culture system modeling the SARS-CoV-2 life cycle Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform Construction of non-infectious SARS-CoV-2 replicons and their application in drug Replication and singlecycle delivery of SARS-CoV-2 replicons Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses Engineering a reliable and convenient SARS-CoV-2 replicon system for analysis of viral RNA synthesis and screening of antiviral inhibitors. mBio Establishing a genetic recombination map for murine coronavirus strain A59 complementation groups Sequence evidence for RNA recombination in field isolates of avian coronavirus infectious bronchitis virus Leader sequences of murine coronavirus mRNAs can be freely reassorted: evidence for the role of free leader RNA in transcription Coronavirus reverse genetics by targeted RNA recombination Recombination between nonsegmented RNA genomes of murine coronaviruses Homologous RNA recombination allows efficient introduction of site-specific mutations into the genome of coronavirus MHV-A59 via synthetic co-replicating RNAs Optimization of targeted RNA recombination and mapping of a novel nucleocapsid gene mutation in the coronavirus mouse hepatitis virus Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier Switching species tropism: an effective way to manipulate the feline coronavirus genome Manipulation of the porcine epidemic diarrhea virus genome using targeted RNA recombination Coronavirus pathogenesis Strategy for systematic assembly of large RNA and DNA genomes: transmissible gastroenteritis virus model Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus Stabilization of a full-length infectious cDNA clone of transmissible gastroenteritis coronavirus by insertion of an intron Complete nucleotide sequence of two generations of a bacterial artificial chromosome cloning vector Recovery of a neurovirulent human coronavirus OC43 from an infectious cDNA clone Molecular characterization of feline infectious peritonitis virus strain DF-2 and studies of the role of ORF3abc in viral cell tropism Construction of a severe acute respiratory syndrome coronavirus infectious cDNA clone and a replicon to study coronavirus RNA synthesis Engineering a replicationcompetent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector Construction and characterization of a human bacterial artificial chromosome library Partition mechanism of F plasmid: two plasmid gene-encoded products and a cis-acting region are involved in partition Conditionally amplifiable BACs: switching from single-copy to high-copy vectors and genomic clones Coronavirus reverse genetic systems: infectious clones and replicons Stabilization of a full-length infectious cDNA clone for duck Tembusu virus by insertion of an intron Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project Targeted modification of a human beta-globin locus BAC clone using GET Recombination and an I-Scei counterselection cassette A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA Two-step redmediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli A new logic for DNA engineering using recombination in Escherichia coli Accelerated genome engineering of Pseudomonas putida by I-SceI-mediated recombination and CRISPR-Cas9 counterselection Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain In vitro assembled, recombinant infectious bronchitis viruses demonstrate that the 5a open reading frame is not essential for replication Reverse genetics with a fulllength infectious cDNA of severe acute respiratory syndrome coronavirus Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice Systematic assembly of a full-length infectious clone of human coronavirus Reverse genetics with a fulllength infectious cDNA of the Middle East respiratory syndrome coronavirus Selective isolation of genomic loci from complex genomes by transformation-associated recombination cloning in the yeast Saccharomyces cerevisiae Cloning, assembly, and modification of the primary human cytomegalovirus isolate toledo by yeast-based transformation-associated recombination Genome-wide engineering of an infectious clone of herpes simplex virus type 1 using synthetic genomics assembly methods Direct isolation of human BRCA2 gene by transformation-associated recombination in yeast Exploiting the yeast Saccharomyces cerevisiae for the study of the organization and evolution of complex genomes A novel bacterium-free method for generation of flavivirus infectious DNA by circular polymerase extension reaction allows accurate recapitulation of viral heterogeneity Reverse genetics systems for SARS-CoV-2 All data generated or analyzed during this study are included in this published article. http://orcid.org/0000-0001-9777-2143Xiaoxue Peng https://orcid.org/0000-0001-8687-9711Ji-An Pan https://orcid.org/0000-0002-2842-4126Deyin Guo https://orcid.org/0000-0002-8297-0814